Mirae Asset Global Investments Co., Ltd. Nevro Corp Transaction History

Mirae Asset Global Investments Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$36.43 - $49.4 $9,908 - $13,436	272 Added 1.85%	15,004 $594,000
Q3 2022 Nov 10, 2022	BUY	$40.66 - $53.03 $179,717 - $234,392	4,420 Added 42.86%	14,732 $687,000
Q2 2022 Jul 26, 2022	BUY	$40.85 - $77.67 $421,245 - $800,933	10,312 New	10,312 $452,000
Q4 2017 Feb 12, 2018	SELL	$65.94 - $93.31 $1.88 Million - $2.66 Million	-28,500 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$80.87 - $91.08 $679,227 - $764,980	8,399 Added 41.78%	28,500 $2.59 Million
Q2 2017 Aug 14, 2017	BUY	N/A	20,101	20,101 $1.5 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.